The dysregulation of the α2-AR pathway may contribute to the release of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1) and IL-6, thus increasing the susceptibility to depression (23). The gene discussed is IL6; the disease is depressive symptom measurement.